ConductScience.org, home
Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer
API referenceFor AI assistants

Trial · NCT02898207

Participant flow108

How many started, completed or left each group, period by period.

41 to 60 of 108

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Dose Level 2STARTEDDose Level 2a: Olaparib 200 mg and Onalespib 80 mg/m^20
Dose Level 2STARTEDDose Level 3a: Olaparib 200 mg and Onalespib 120 mg/m^20
Dose Level 2COMPLETEDDose Level 0: Olaparib 200 mg and Onalespib 20 mg/m^20
Dose Level 2COMPLETEDDose Level 1: Olaparib 200 mg and Onalespib 40 mg/m^20
Dose Level 2COMPLETEDDose Level 2: Olaparib 300 mg and Onalespib 40 mg/m^26
Dose Level 2COMPLETEDDose Level 3: Olaparib 300 mg and Onalespib 80 mg/m^20
Dose Level 2COMPLETEDDose Level 2a: Olaparib 200 mg and Onalespib 80 mg/m^20
Dose Level 2COMPLETEDDose Level 3a: Olaparib 200 mg and Onalespib 120 mg/m^20
Dose Level 2NOT COMPLETEDDose Level 0: Olaparib 200 mg and Onalespib 20 mg/m^20
Dose Level 2NOT COMPLETEDDose Level 1: Olaparib 200 mg and Onalespib 40 mg/m^20
Dose Level 2NOT COMPLETEDDose Level 2: Olaparib 300 mg and Onalespib 40 mg/m^20
Dose Level 2NOT COMPLETEDDose Level 3: Olaparib 300 mg and Onalespib 80 mg/m^20
Dose Level 2NOT COMPLETEDDose Level 2a: Olaparib 200 mg and Onalespib 80 mg/m^20
Dose Level 2NOT COMPLETEDDose Level 3a: Olaparib 200 mg and Onalespib 120 mg/m^20
Dose Level 3STARTEDDose Level 0: Olaparib 200 mg and Onalespib 20 mg/m^20
Dose Level 3STARTEDDose Level 1: Olaparib 200 mg and Onalespib 40 mg/m^20
Dose Level 3STARTEDDose Level 2: Olaparib 300 mg and Onalespib 40 mg/m^20
Dose Level 3STARTEDDose Level 3: Olaparib 300 mg and Onalespib 80 mg/m^27
Dose Level 3STARTEDDose Level 2a: Olaparib 200 mg and Onalespib 80 mg/m^20
Dose Level 3STARTEDDose Level 3a: Olaparib 200 mg and Onalespib 120 mg/m^20

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Previous pageNext page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02898207/flow?page=3

API referenceFor AI assistants